About Nephron Pharmaceuticals
Nephron Pharmaceuticals is a company based in Florida (United States) founded in 1937.. Nephron Pharmaceuticals has raised $625 million across 5 funding rounds from investors including PNC, Blackrockbkcc and WhiteHawk Capital Partners. Nephron Pharmaceuticals offers products and services including Inhalation Products, 503B Outsourcing, and Contract Manufacturing.
- Headquarter Florida, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nephron Pharmaceuticals Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$625 M (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
PNC
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nephron Pharmaceuticals
Nephron Pharmaceuticals offers a comprehensive portfolio of products and services, including Inhalation Products, 503B Outsourcing, and Contract Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops and manufactures solutions for respiratory ailments like asthma and COPD.
Provides sterile pre-filled medications to address shortages in hospitals.
Offers sterile medication production for medical facilities across America.
Funding Insights of Nephron Pharmaceuticals
Nephron Pharmaceuticals has successfully raised a total of $625M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(01 Aug 2014)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Debt – Conventional - Nephron Pharmaceuticals | Valuation |
investors |
|
| Sep, 2023 | Amount | Private Equity Round - Nephron Pharmaceuticals | Valuation | Blackrockbkcc , PNC |
|
| Aug, 2017 | Amount | Debt – Conventional - Nephron Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nephron Pharmaceuticals
Nephron Pharmaceuticals has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include PNC, Blackrockbkcc and WhiteHawk Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage technology investments are made by TCP Venture Capital.
|
Founded Year | Domain | Location | |
|
Provides asset-based financing solutions to middle market private and public companies.
|
Founded Year | Domain | Location | |
|
Blackrockbkcc is maintained as a web-based entity.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nephron Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nephron Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nephron Pharmaceuticals Comparisons
Competitors of Nephron Pharmaceuticals
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nephron Pharmaceuticals
Frequently Asked Questions about Nephron Pharmaceuticals
When was Nephron Pharmaceuticals founded?
Nephron Pharmaceuticals was founded in 1937 and raised its 1st funding round 77 years after it was founded.
Where is Nephron Pharmaceuticals located?
Nephron Pharmaceuticals is headquartered in Florida, United States. It is registered at Florida, Puerto Rico, United States.
Is Nephron Pharmaceuticals a funded company?
Nephron Pharmaceuticals is a funded company, having raised a total of $625M across 5 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $330M, raised on Aug 01, 2014.
What does Nephron Pharmaceuticals do?
Nephron Pharmaceuticals was founded in 1937 and operates in the pharmaceutical sector, focusing on sterile products. Generic respiratory medications are produced, along with pre-filled sterile options to address drug shortages. Contract manufacturing and 503B outsourcing services are offered, covering development, production, and packaging in facilities located in Florida and Puerto Rico. Community initiatives and educational programs in pharmacy and healthcare are supported.
What products or services does Nephron Pharmaceuticals offer?
Nephron Pharmaceuticals offers Inhalation Products, 503B Outsourcing, and Contract Manufacturing.
Who are Nephron Pharmaceuticals's investors?
Nephron Pharmaceuticals has 4 investors. Key investors include PNC, Blackrockbkcc, WhiteHawk Capital Partners, and TCP Venture Capital.